🇺🇸 FDA
Patent

US 10072070

Potent anti-influenza A neuraminidase subtype N1 antibody

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10072070 (Potent anti-influenza A neuraminidase subtype N1 antibody) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/42